Table 1. The finalized TRAIL model reactions and parameters. Note that to simulate each KD condition, we imposed null parameter value(s) for all reaction(s) involving the KD molecule.
Reaction/process | k (1/s) | Remarks | |||
---|---|---|---|---|---|
1 | Apo2/TRAIL | → | TRAIL receptor | 8.13E-3 | Binding of TRAIL ligand to receptor |
2 | TRAIL receptor | → | Receptor process 1 | 8.17E-3 | O-glycosylation, internalization of receptors, formation of lipid rafts, etc. |
3 | Receptor process 1 | → | Receptor process 2 | 7.89E-3 | |
4 | Receptor process 1 | → | Y | 1.04E-3 | Activation of novel molecule Y |
5 | Y | → | MKK3/6 | 4.31E-1 | Rapid activation of MKK3/6 via Y |
6 | Receptor process 2 | → | FADD | 1.08E-3 | FADD binds to TRAIL receptors |
7 | FADD | → | pro-caspase-8 | 1.06E-3 | pro-caspase-8 binds to FADD |
8 | pro-caspase-8 | → | CUL3 | 1,99E-3 | Activation of CUL3 |
9 | pro-caspase-8 | → | c-FLIP | 1.00E-3* | Activation of cFLIP (*arbitrary value) |
10 | CUL3 | → | Ubiquitination of caspase-8 | 1.00E-2 | Ubiquitination of caspase-8 |
11 | Ubiquitination of caspase-8 | → | p62 | 9.92E-1 | Activation of p62/sequestosome |
12 | Ubiquitination of caspase-8 | → | TRAF2 | 8.67E-2 | Activation of TRAF2 by pro-caspase-8 |
13 | p62 | → | Z | 3.09E-1 | Activation of novel molecule Z by p62 |
14 | p62 | → | RIP1 | 6.77E-2 | Activation of RIP1 by p62 |
15 | p62 | → | caspase-8 (active form) | 2.72E-2 | Activation of caspase-8 (cleaved) |
16 | caspase-8 (active form) | → | tBid | 1.13E-5 | Activation of tBid by caspase-8 |
17 | caspase-8 (active form) | → | caspase-3 | 1.48E-6 | Activation of caspase-3 (extrinsic pathway) |
18 | tBid | → | mitochondria | 5.09E-2 | Apoptotic intrinsic pathway via tBid |
19 | mitochondria | → | Cytochrome C | 2.64E-1 | Activation of Cytochrome C |
20 | mitochondria | → | Smac | 2.79E-1 | Activation of Smac |
21 | Cytochrome C | → | caspase-3 | 2.81E-1 | Activation of caspase-3 via apoptosome |
22 | Smac | → | caspase-3 | 1.68E-1 | Smac-dependent activation of caspase-3 |
23 | caspase-3 | → | Apoptosis process | 8.85E-3 | caspase-3 depletion term |
24 | RIP1 | → | IKK | 4.00E-4 | Activation of IKK by RIP1 |
25 | RIP1 | → | MKK3/6 | 5.04E-1 | Activation of MKK3/6 by RIP1 (novel) |
26 | IKK | → | IκB | 3.45E-1 | Activation of IκB by IKK |
27 | IκB | → | NF-κB | 8.99E-4 | Activation of NF-κB by IκB |
28 | NF-κB | → | Survival process | 1.00E-1* | NF-κB depletion term (*arbitrary value) |
29 | TRAF2 | → | MKK3/6 | 7.24E-5 | Activation of MKK3/6 by TRAF2 |
30 | TRAF2 | → | MKK4/7 | 2.63E-6 | Activation of JNK pathway by TRAF2 |
31 | MKK3/6 | → | p38 | 2.37E-4 | Activation of p38 by MKK3/6 |
32 | p38 | → | Survival process | 1.31E-5 | p38 depletion term |
33 | Y | → | Z | 3.07E-1 | Intermediates for delayed JNK activation |
34 | Z | → | X1 | 8.76E-4 | |
35 | X1 | → | X2 | 3.18E-3 | |
36 | X2 | → | X3 | 7.48E-3 | |
37 | X3 | → | MKK4/7 | 2.21E-3 | Activation of JNK through bypass |
38 | MKK4/7 | → | JNK | 1.81E-4 | Activation of JNK by MKK4/7 |
39 | JNK | → | Survival process | 2.36E-4 | JNK depletion term |
Highlighted rows indicate novel features of the TRAIL signaling pathway.